# OnCo record stx-0712 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/stx-0712/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "stx-0712" ;
  schema:name "STX-0712"@en ;
  schema:description "STX-0712 is an experimental cyTAC with ADCC-enhanced platform antibody from Solu Therapeutics, in phase 1 trials for chronic myelomonocytic leukaemia and acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/drugs/stx-0712/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://solutherapeutics.com/>, <https://solutherapeutics.com/>, <https://clinicaltrials.gov/api/v2/studies/NCT06950034>, <https://clinicaltrials.gov/search?intr=STX-0712> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "CyTAC (cytotoxicity targeting chimera) with ADCC-enhanced platform antibody" ;
  onco:cancers <https://onco.cc/cancers/cmml/>, <https://onco.cc/cancers/aml/> ;
  onco:companies <https://onco.cc/companies/solu-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06950034/> .